Synthesis of new functionalized citric acid-based dendrimers as nanocarrier agents for drug delivery

BioImpacts

Volumn 1, Issue 1, 2011, Pages 63-69

  Namazi, Hassan ^a   Motamedi, Sanaz ^a   Namvari, Mina ^a  

^a UNIVERSITY OF TABRIZ   (Iran)

Author keywords

Citric acid; Dendrimer; Drug delivery; Encapsulation; Nanocarrier; Naproxen

Indexed keywords

CITRIC ACID POLYETHYLENE GLYCOL CITRIC ACID TRIBLOCK DENDRIMER; DENDRIMER; IMIDAZOLE; NANOCARRIER; NAPROXEN; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADABILITY; CHEMICAL INTERACTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROPHILICITY; HYDROLYSIS; LIGHT SCATTERING; PARTICLE SIZE; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 84876698090     PISSN: 22285652     EISSN: 22285660     Source Type: Journal    
DOI: 10.5681/bi.2011.009     Document Type: Article

References (27)

1. Ambade AV, Savariar EN and Thayumanavan S. 2005. Dendrimeric micelles for controlled drug release and targeted delivery. Molecular pharmaceutics, 2(4), 264-72.
2. Basavaraj BV, Hiren MB and Ganesh KB. 2009. Dendrimers: emerging polymers for drug-delivery systems. Eur.J. Pharm. Sci., 38185-196.
3. Boas U and Heegaard PMH. 2004. Dendrimers in drug research. Chemical Society Reviews, 33(1), 43-63.
4. Crampton HL and Simanek EE. 2007. Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers. Polymer International, 56(4), 489-496.
5. D'Emanuele A and Attwood D. 2005. Dendrimer-drug interactions. Advanced Drug Delivery Reviews, 57(15), 2147-62.
6. Didehban K, Namazi H and Entezami AA. 2009a. Dendrimer-based hydrogen-bonded liquid crystalline complexes: Synthesis and characterization. European Polymer Journal, 45(6), 1836-1844.
7. Didehban K, Namazi H and Entezami AA. 2009b. Synthesis and characterization of liquid crystalline diethanolamine-based dendrimers. Polymers for Advanced Technologies, 20(12), 1127-1135.
8. Ganta S, Devalapally H, Shahiwala A and Amiji M. 2008. A review of stimuli-responsive nanocarriers for drug and gene delivery. Journal of Controlled Release, 126(3), 187-204.
9. Haririan I, Alavidjeh MS, Khorramizadeh MR, Ardestani MS, Ghane ZZ and Namazi H. 2010. Anionic linear-globular dendrimer-cis-platinum (II) conjugates promote cytotoxicity in vitro against different cancer cell lines. International journal of nanomedicine, 563-75.
10. Jansen JFGA, Meijer EW and Debrabandervandenberg EMM. 1995. The Dendritic Box - Shape-Selective Liberation of Encapsulated Guests. Journal of the American Chemical Society, 117(15), 4417-4418.
11. Klajnert B and Bryszewska M. 2001. Dendrimers: properties and applications. Acta Biochimica Polonica, 48(1), 199-208.
12. Kurtoglu YE, Navath RS, Wang B, Kannan S, Romero R and Kannan RM. 2009. Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery. Biomaterials, 30(11), 2112-21.
13. Liu MJ, Kono K and Frechet JMJ. 2000. Water-soluble dendritic unimolecular micelles: Their potential as drug delivery agents. Journal of Controlled Release, 65(1-2), 121-131.
14. Namazi H and Adeli M. 2003. Novel linear-globular thermoreversible hydrogel ABA type copolymers from dendritic citric acid as the A blocks and poly(ethyleneglycol) as the B block. European Polymer Journal, 39(7), 1491-1500.
15. Namazi H and Adeli M. 2005. Dendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agents. Biomaterials, 26(10), 1175-83.
16. Namazi H and Jafarirad S. 2011. Controlled release of linear-dendritic hybrids of carbosiloxane dendrimer: The effect of hybrid's amphiphilicity on drug-incorporation; hybrid-drug interactions and hydrolytic behavior of nanocarriers. International journal of pharmaceutics, 407(1-2), 167-173.
17. Paleos CM, Tsiourvas D, Sideratou Z and Tziveleka L. 2004. Acid- and salt-triggered multifunctional poly(propylene imine) dendrimer as a prospective drug delivery system. Biomacromolecules, 5(2), 524-529.
18. Qiu LY and Bae YH. 2006. Polymer architecture and drug delivery. Pharmaceutical Research, 23(1), 1-30.
19. Schenning APHJ, Elissen-Roman C, Weener JW, Baars MWPL, van der Gaast SJ and Meijer EW. 1998. Amphiphilic dendrimers as building blocks in supramolecular assemblies. Journal of the American Chemical Society, 120(32), 8199-8208.
20. Sigal GB, Mammen M, Dahmann G and Whitesides GM. 1996. Polyacrylamides bearing pendant alpha-sialoside groups strongly inhibit agglutination of erythrocytes by influenza virus: The strong inhibition reflects enhanced binding through cooperative polyvalent interactions. Journal of the American Chemical Society, 118(16), 3789-3800.
21. Spataro G, Malecaze F, Turrin CO, Soler V, Duhayon C, Elena PP, et al. 2010. Designing dendrimers for ocular drug delivery. European Journal of Medicinal Chemistry, 45(1), 326-334.
22. Svenson S and Tomalia DA. 2005. Dendrimers in biomedical applications--reflections on the field. Advanced Drug Delivery Reviews, 57(15), 2106-29.
23. Tomalia DA, Baker H, Dewald JR, Hall M, Kallos G, Martin S, et al. 1985. A New Class of Polymers: Starburst-Dendritic Macromolecules. Polym J, 17(1), 117-132.
24. Tomalia DA, Naylor AM and Goddard WA. 1990. Starburst dendrimers: molecular level control of size, shape, suface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed Engl, 29138-175.
25. Torchilin VP. 2001. Structure and design of polymeric surfactant-based drug delivery systems. Journal of Controlled Release, 73(2-3), 137-172.
26. Veronese FM, Marsilio F, Caliceti P, De Filippis P, Giunchedi P and Lora S. 1998. Polyorganophosphazene microspheres for drug release: polymer synthesis, microsphere preparation, in vitro and in vivo naproxen release. Journal of Controlled Release, 52(3), 227-237.
27. Wang Z, Itoh Y, Hosaka Y, Kobayashi I, Nakano Y, Maeda I, et al. 2003. Mechanism of enhancement effect of dendrimer on transdermal drug permeation through polyhydroxyalkanoate matrix. Journal of bioscience and bioengineering, 96(6), 537-40.